Concentrix (CNXC) stock came under pressure after first quarter earnings showed weaker profitability, with operating margin contraction linked to rising costs, and new revenue and earnings guidance that was below market expectations.
See our latest analysis for Concentrix.
The market reaction has been sharp, with a 1-day share price return of 6.84% and a 7-day share price return of 19.85%. This has contributed to a 90-day share price return of 40.83% and a 1-year total shareholder return of 44.41%. These figures signal fading momentum as investors reassess profitability and guidance alongside recent buybacks, AI related contract wins, and the affirmed dividend.
If this earnings reset has you reassessing where growth could come from next, it may be worth scanning for other AI focused opportunities through the Simply Wall St screener for 35 AI infrastructure stocks
With Concentrix shares down sharply over 1 year and the stock trading at a reported intrinsic discount of 78.64%, the key question now is whether investors are seeing a genuine mispricing or if markets are already factoring in future growth.
Most Popular Narrative: 60.3% Undervalued
Concentrix's most followed valuation narrative points to a fair value of $62.20 versus the last close of $24.67. This frames a wide gap that hinges on how its AI and platform rollouts play out over time.
The company is monetizing its iX Hello products, designed to be accretive to earnings by the end of fiscal 2025. The transition from pilot phases to deployments is expected to positively impact earnings growth.
Curious what earnings path is needed to back that fair value? The narrative leans heavily on steadier revenue progress, rising margins and a lower future earnings multiple. The mix of buybacks, acquisition synergies and AI driven contracts is presented as central to the cash flow story.
Result: Fair Value of $62.20 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on Webhelp integration staying on track and on Concentrix managing its sizeable US$4.9b debt load without squeezing margins or cash flows.
Find out about the key risks to this Concentrix narrative.
Next Steps
If this mix of concerns and potential upside feels finely balanced, now is the moment to review the underlying data and form your own view using our breakdown of 3 key rewards and 3 important warning signs
Ready to spot your next idea?
If Concentrix has sharpened your thinking, do not stop here. Let the same data driven approach guide you toward other opportunities that match your style and risk comfort.
- Pinpoint quality at a discount by scanning companies that screen as 55 high quality undervalued stocks before the crowd catches on.
- Strengthen your income stream by checking out businesses tagged as 12 dividend fortresses with yields that could support regular payouts.
- Prioritize resilience by reviewing companies highlighted in the 74 resilient stocks with low risk scores so potential surprises are less likely to catch you off guard.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com